Used in pharmaceutical synthesis as an intermediate for proton pump inhibitors, particularly in the development of rabeprazole analogs. Enhances metabolic stability and bioavailability in acid-suppressive medications. Employed in research to improve gastric acid control with prolonged duration of action. Investigated for optimized drug delivery in gastroesophageal reflux disease (GERD) and peptic ulcer treatment.